News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Kazia Therapeutics.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Health Powerplays: Biotechs hitting it out of the park
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Antisense Therapeutics’ FDA ruling could be worth ‘hundreds of millions’
Health & Biotech
World-renown cancer institute to investigate Kazia Therapeutics drug
Health & Biotech
Dr Boreham’s Crucible: Kazia reaches the ‘endgame’
Health & Biotech
Check up: Health sector slips as earning season ends
Experts
Scopo’s health powerplays: A healthy earnings season
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s in on the conspiracy today?
Health & Biotech
Kazia Therapeutics continues strong month with more good news from US health regulators
News
10 at 10: These ASX stocks are perched high up this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Could a weaker US dollar reignite global growth?
News
10 at 10: These ASX stocks have reached a milestone this morning
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
Health & Biotech